Oxotremorine-M potentiates NMDA receptors by muscarinic receptor dependent and independent mechanisms
Authors:
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 495 (1) , 481-486
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Company
This publication has 23 references indexed in Scilit:
- Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the HippocampusCerebral Cortex, 2015
- The cholinergic system in aging and neuronal degenerationBehavioural Brain Research, 2011
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Reconstitution of Muscarinic Modulation of the KCNQ2/KCNQ3 K+Channels That Underlie the Neuronal M CurrentThe Journal of Neuroscience, 2000
- Inhibition of KCNQ1‐4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptorsThe Journal of Physiology, 2000
- Activation of the genetically defined m1 muscarinic receptor potentiates N -methyl- d -aspartate (NMDA) receptor currents in hippocampal pyramidal cellsProceedings of the National Academy of Sciences, 1998
- Endogenous ACh enhances striatal NMDA‐responses via M1‐like muscarinic receptors and PKC activationEuropean Journal of Neuroscience, 1998
- Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer diseaseProceedings of the National Academy of Sciences, 1996
- Acetylcholine potentiates responses to in the rat hippocampusNeuroscience Letters, 1990
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990